MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 8, Issue 5, Pages e2776
Publisher
Springer Nature
Online
2017-05-11
DOI
10.1038/cddis.2017.188
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Novel phosphatidylinositol 3-kinase inhibitor BKM120 enhances the sensitivity of multiple myeloma to bortezomib and overcomes resistance
- (2016) Wenjun Yu et al. LEUKEMIA & LYMPHOMA
- Bufalin loaded biotinylated chitosan nanoparticles: An efficient drug delivery system for targeted chemotherapy against breast carcinoma
- (2014) Xin Tian et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- AKT as a therapeutic target in multiple myeloma
- (2014) Niamh A Keane et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Critical Role of AKT Protein in Myeloma-induced Osteoclast Formation and Osteolysis
- (2013) Huiling Cao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting Poly (ADP-Ribose) Polymerase Partially Contributes to Bufalin-Induced Cell Death in Multiple Myeloma Cells
- (2013) He Huang et al. PLoS One
- Proteasome inhibitors in multiple myeloma: 10 years later
- (2012) P. Moreau et al. BLOOD
- Molecular Targets for the Treatment of Multiple Myeloma
- (2012) Marco Rossi et al. CURRENT CANCER DRUG TARGETS
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- (2011) Timothy A. Yap et al. JOURNAL OF CLINICAL ONCOLOGY
- MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo
- (2010) H. Hirai et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2
- (2009) M. Gupta et al. BLOOD
- Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM)
- (2009) M. Roussel et al. BLOOD
- Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer
- (2009) Zhiqiang Meng et al. CANCER
- Microarray and biochemical analysis of bufalin-induced apoptosis of HL-60 Cells
- (2008) Ailiang Chen et al. BIOTECHNOLOGY LETTERS
- Endothelin-1 Couples βPix to p66Shc: Role of βPix in Cell Proliferation through FOXO3a Phosphorylation and p27kip1 Down-Regulation Independently of Akt
- (2008) Ahmed Chahdi et al. MOLECULAR BIOLOGY OF THE CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now